The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease
Vpr 介导的细胞周期失调在 HIV 相关肾病中的作用
基本信息
- 批准号:10678878
- 负责人:
- 金额:$ 74.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-15 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS-Associated NephropathyAccelerationAnimal ModelAnti-Retroviral AgentsAntimitotic AgentsApoptosisApoptoticAtrophicAttenuatedBiopsy SpecimenBypassCDC2 geneCDT1 GeneCell CycleCell Cycle ArrestCell Cycle DeregulationCell DeathCellsCessation of lifeChromatinChronicChronic Kidney FailureClinicalComplementCytokinesisDNA Replication FactorDNA biosynthesisDefectDevelopmentDiabetes MellitusDiagnosisDisease ProgressionEnd stage renal failureEpithelial CellsEquilibriumFibrosisG2/M ArrestGene ExpressionGenesHIVHIV InfectionsHIV therapyHIV-1HumanHyperplasiaHypertrophyIn SituIn VitroIncidenceIndividualInflammationInjuryInjury to KidneyInterventionKidneyKidney DiseasesKnowledgeLicensingLicensing FactorMeasuresMediatingMitosisMitoticMitotic Cell CycleModelingMolecularMonitorMusPLK1 genePathogenesisPathologicPatientsPhenotypePhosphotransferasesPolyploid CellsPolyploidyPrevalenceProteinsProteinuriaRNAReporterReportingRiskRoleStudy modelsTP53 geneTherapeutic EffectTherapeutic InterventionTimeTransgenic MiceTubular formationViral Load resultViral Proteinsage relatedantiretroviral therapycancer cellcell injurycomorbiditycomparativeeffective therapyepidemiological modelin vivoinhibitorinterstitialkidney biopsykidney fibrosismouse modelnew therapeutic targetnovelpharmacologicprematuresingle-cell RNA sequencingtranscriptome sequencingtranscriptomic profilingtranscriptomicsvpr Gene Products
项目摘要
PROJECT SUMMARY
With the widespread use of combination antiretroviral agents, the incidence of HIV-associated nephropathy
(HIVAN) has dramatically decreased in the recent years. Yet, the prevalence of chronic kidney disease (CKD)
and end-stage kidney disease in patients living with HIV remains high, suggesting that HIV predisposes
patients to increased risk for chronic kidney disease. Indeed, several lines of evidence from recent
epidemiological and animal model studies indicate that concurrent HIV infection and age-related comorbidities,
such as diabetes mellitus, have a synergistic effect on the incidence of chronic kidney disease, thereby
necessitating an examination of mechanisms by which HIV infection even at low viral load accelerates the
progression of CKD. Among the HIV-1 viral proteins, we previously showed that HIV viral protein R (Vpr) can
induce cell cycle dysregulation, apoptosis, and polyploidy in renal tubular cells. However, the importance and
consequences of Vpr-mediated cell cycle arrest and polyploidy has not been fully explored in the setting of
kidney disease. In this proposal, we will further dissect the mechanisms dictating the cell fates of Vpr-
expressing renal tubular using in vitro approaches (Aim 1). Similarly, using transgenic mice expressing Vpr in
renal tubular epithelial cells, we will characterize the cell cycle dysregulation and gene expression at single-cell
levels, and determine whether the pharmacological intervention of cell cycle dysregulation can attenuate
kidney disease progression in this model, as well as in HIVAN mouse model, Tg26 (Aim 2). To complement the
findings in Aims 1 and 2, we will assess the expression of genes and cell cycle regulators in kidney biopsy
samples of HIV+ CKD patients (Aim 3). We will also perform transcriptomic profiling for comparative analyses
with findings in murine kidneys. Our results will provide a better understanding of the underlying molecular
mechanisms by which chronic HIV infection accelerates the progression of CKD and a proof-of-concept for
novel target treatment for CKD in HIV patients.
项目总结
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
HIV-1 infection of renal epithelial cells: 30 years of evidence from transgenic animal models, human studies and in vitro experiments.
- DOI:10.1186/s12977-023-00617-8
- 发表时间:2023-03-16
- 期刊:
- 影响因子:3.3
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Cijiang He其他文献
Bisphenol A promotes hyperuricemia via activating xanthine oxidase
双酚A通过激活黄嘌呤氧化酶促进高尿酸血症
- DOI:
10.1096/fj.201700755r - 发表时间:
2017-10 - 期刊:
- 影响因子:0
- 作者:
Linqiang Ma;Jinbo Hu;Jiayu Li;Yi Yang;Linkun Zhang;Lingyun Zou;Rufei Gao;Yue Wang;Ting Luo;Xiaojiao Xiang;Hua Qing;Xiaoqiu Xiao;Chaodong Wu;Zhihong Wang;John Cijiang He;Qifu Li;Shumin Yang - 通讯作者:
Shumin Yang
An update: the role of Nephrin inside and outside the kidney
- DOI:
10.1007/s11427-015-4844-1 - 发表时间:
2015-04-29 - 期刊:
- 影响因子:9.500
- 作者:
XueZhu Li;John Cijiang He - 通讯作者:
John Cijiang He
A Newly Identified Protective Role of C5a Receptor 1 in Kidney Tubules against Toxin-Induced Acute Kidney Injury
新发现的C5a受体1在肾小管中对毒素诱导的急性肾损伤的保护作用
- DOI:
10.1016/j.ajpath.2024.10.003 - 发表时间:
2025-01-01 - 期刊:
- 影响因子:3.600
- 作者:
Samuel Mon-Wei Yu;Emily King;Miguel Fribourg;Susan Hartzell;Liam Tsou;Logan Gee;Vivette D. D'Agati;Joshua M. Thurman;John Cijiang He;Paolo Cravedi - 通讯作者:
Paolo Cravedi
Bisphenol A promotes hyperuricemia via activating xanthine oxidase
- DOI:
doi: 10.1096/fj.201700755R - 发表时间:
- 期刊:
- 影响因子:
- 作者:
Linqiang Ma;Jinbo Hu;Jiayu Li;Yi Yang;Linkun Zhang;Lingyun Zou;Rufei Gao;Chuan Peng;Yue Wang;Ting Luo;Xiaojiao Xiang;Hua Qing;Xiaoqiu Xiao;Chaodong Wu;Zhihong Wang;John Cijiang He;Qifu Li;Shumin Yang - 通讯作者:
Shumin Yang
RETRACTED ARTICLE: LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma
撤回文章:长链非编码 RNA HOTAIR 通过抑制肾细胞癌中的 miR-217 调节 HIF-1α/AXL 信号通路
- DOI:
10.1038/cddis.2017.181 - 发表时间:
2017-05-11 - 期刊:
- 影响因子:9.600
- 作者:
Quan Hong;Ou Li;Wei Zheng;Wen-zhen Xiao;Lu Zhang;Di Wu;Guang-yan Cai;John Cijiang He;Xiang-mei Chen - 通讯作者:
Xiang-mei Chen
John Cijiang He的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Cijiang He', 18)}}的其他基金
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease
Vpr 介导的细胞周期失调在 HIV 相关肾病中的作用
- 批准号:
10527702 - 财政年份:2022
- 资助金额:
$ 74.03万 - 项目类别:
Role of RARRES1 in diabetic kidney disease
RARRES1 在糖尿病肾病中的作用
- 批准号:
10278234 - 财政年份:2021
- 资助金额:
$ 74.03万 - 项目类别:
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
阐明介导 HIV 感染者 DKD 进展的分子机制
- 批准号:
10364063 - 财政年份:2021
- 资助金额:
$ 74.03万 - 项目类别:
Role of RARRES1 in diabetic kidney disease
RARRES1 在糖尿病肾病中的作用
- 批准号:
10662465 - 财政年份:2021
- 资助金额:
$ 74.03万 - 项目类别:
Role of RARRES1 in diabetic kidney disease
RARRES1 在糖尿病肾病中的作用
- 批准号:
10461883 - 财政年份:2021
- 资助金额:
$ 74.03万 - 项目类别:
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
阐明介导 HIV 感染者 DKD 进展的分子机制
- 批准号:
10531888 - 财政年份:2021
- 资助金额:
$ 74.03万 - 项目类别:
PP2A as a drug target for diabetic kidney disease
PP2A作为糖尿病肾病的药物靶点
- 批准号:
10399582 - 财政年份:2020
- 资助金额:
$ 74.03万 - 项目类别:
PP2A as a drug target for diabetic kidney disease
PP2A作为糖尿病肾病的药物靶点
- 批准号:
10627834 - 财政年份:2020
- 资助金额:
$ 74.03万 - 项目类别:
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies
增殖性肾小球病中足细胞-壁上皮细胞串扰的介导机制
- 批准号:
10434116 - 财政年份:2020
- 资助金额:
$ 74.03万 - 项目类别:
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies
增殖性肾小球病中足细胞-壁上皮细胞串扰的介导机制
- 批准号:
10119964 - 财政年份:2020
- 资助金额:
$ 74.03万 - 项目类别:
相似海外基金
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 74.03万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 74.03万 - 项目类别:
Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 74.03万 - 项目类别:
Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 74.03万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 74.03万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 74.03万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 74.03万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 74.03万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 74.03万 - 项目类别:
Continuing Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
- 批准号:
2307983 - 财政年份:2023
- 资助金额:
$ 74.03万 - 项目类别:
Standard Grant














{{item.name}}会员




